Institut Bergonié
Clinical trials sponsored by Institut Bergonié, explained in plain language.
-
Cancer combo study pulled before starting
Disease control TerminatedThis study was planned to test two drugs, Ezabenlimab and BI 907828, in people with advanced solid tumors like sarcoma, lung, breast, colorectal, or bile duct cancer. The goal was to see if the combination could control tumor growth for at least 24 weeks. However, the study was w…
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated May 17, 2026 01:00 UTC
-
Could an immunotherapy boost chemo for sarcoma patients?
Disease control OngoingThis study tests whether adding the immunotherapy drug retifanlimab to standard chemotherapy before surgery can improve outcomes for people with certain soft-tissue sarcomas. About 66 adults with grade 2 or 3 sarcomas that can be surgically removed will be randomly assigned to re…
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated May 17, 2026 00:53 UTC
-
Lung cancer combo therapy study halted before start
Disease control TerminatedThis study was designed for people with advanced non-small cell lung cancer that could not be removed by surgery. It planned to use a combination of chemotherapy drugs (cisplatin and docetaxel) along with radiation therapy to shrink tumors and control the disease. However, the st…
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New biopsy method could prevent cancer spread during fibroid surgery
Diagnosis OngoingThis study tests whether a vaginal ultrasound-guided biopsy can accurately identify cancerous uterine tumors before surgery. If successful, it could help doctors avoid using morcellation—a technique that can accidentally spread cancer—in women with suspicious fibroids. The study …
Phase: NA • Sponsor: Institut Bergonié • Aim: Diagnosis
Last updated May 13, 2026 15:58 UTC
-
New monitoring may ease pain after ovarian cancer surgery
Symptom relief OngoingThis study tests whether using a special monitor (ANI) during ovarian cancer surgery to guide pain medicine can lower the chance of chronic pain three months after the operation. About 126 women having open surgery for ovarian cancer will take part. The goal is to see if this app…
Phase: NA • Sponsor: Institut Bergonié • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
Beauty care after breast surgery: a missed chance to boost body image
Symptom relief TerminatedThis study aimed to see if offering beauty treatments (like skincare or makeup) to women right after breast cancer surgery could improve how they feel about their bodies and their overall quality of life. It planned to compare women who received these treatments with those who di…
Sponsor: Institut Bergonié • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC
-
New study to track cancer risk in rare genetic condition
Knowledge-focused TerminatedThis study follows 430 people with Cowden's disease (a PTEN gene mutation) to see how often they develop cancer. Researchers will track any cancers, especially breast and thyroid, over time. The goal is to better understand cancer risks in this group to improve future monitoring …
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 17, 2026 00:59 UTC
-
Prostate cancer chemokine study withdrawn before enrollment
Knowledge-focused TerminatedThis study was designed to observe and measure certain proteins called chemokines in the blood, urine, and tumors of people with prostate cancer. The goal was to see how these protein levels change over time and relate to the disease. However, the study was withdrawn before any p…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 17, 2026 00:49 UTC
-
Can a simple online check-in keep elderly cancer patients safe at home?
Knowledge-focused OngoingThis study looks at whether people over 65 with cancer can use an online system to regularly report their symptoms and quality of life during treatment. The goal is to see if this kind of remote monitoring is practical and helpful for managing care at home. About 33 participants …
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 17, 2026 00:47 UTC
-
Why some women feel more pain after breast cancer surgery: a study that never started
Knowledge-focused TerminatedThis study aimed to find out if certain psychological and social factors make women more likely to develop long-term pain after breast cancer surgery. Researchers planned to follow women having a mastectomy or lumpectomy and measure their pain levels. However, the study was withd…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 17, 2026 00:46 UTC
-
Study reveals how sarcoma surgery impacts Seniors' daily function
Knowledge-focused OngoingThis study tracks 25 adults aged 70+ who had surgery for soft tissue sarcoma in the leg. Researchers measure changes in physical function, quality of life, and mobility to understand what affects recovery. The goal is to help doctors better predict and support functional outcomes…
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Muscle loss may affect ovarian cancer treatment timing
Knowledge-focused OngoingThis study checks for muscle loss (sarcopenia) in 25 women with advanced ovarian cancer before they start chemotherapy. Researchers use CT scans to measure muscle mass and see how it relates to treatment timing. The goal is to better understand how muscle health affects care, not…
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC
-
Ultrasound zaps breast tumors before mastectomy in aborted trial
Knowledge-focused TerminatedThis study aimed to see if MRI-guided focused ultrasound could safely destroy breast tumors before mastectomy. It was designed for women with invasive breast cancer needing breast removal. However, the study was withdrawn before any participants were enrolled, so no results are a…
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC
-
Experts unite to fix how cancer trials measure success
Knowledge-focused OngoingThis study brings together 265 experts to create clear, consistent definitions for key time-to-event endpoints in cancer clinical trials, such as progression-free survival. By standardizing these definitions across different cancer types, researchers hope to make trial results ea…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 06, 2026 16:13 UTC